Cargando…

Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy

Bimetallic nanomaterials (BMNs) composed of two different metal elements have certain mixing patterns and geometric structures, and they often have superior properties than monometallic nanomaterials. Bimetallic-based nanomaterials have been widely investigated and extensively used in many biomedica...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Guiming, Gao, Fucheng, Wang, Yandong, Zhang, Jie, Zhao, Li, Jiang, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783205/
https://www.ncbi.nlm.nih.gov/pubmed/36557846
http://dx.doi.org/10.3390/molecules27248712
_version_ 1784857522450989056
author Niu, Guiming
Gao, Fucheng
Wang, Yandong
Zhang, Jie
Zhao, Li
Jiang, Yanyan
author_facet Niu, Guiming
Gao, Fucheng
Wang, Yandong
Zhang, Jie
Zhao, Li
Jiang, Yanyan
author_sort Niu, Guiming
collection PubMed
description Bimetallic nanomaterials (BMNs) composed of two different metal elements have certain mixing patterns and geometric structures, and they often have superior properties than monometallic nanomaterials. Bimetallic-based nanomaterials have been widely investigated and extensively used in many biomedical fields especially cancer therapy because of their unique morphology and structure, special physicochemical properties, excellent biocompatibility, and synergistic effect. However, most reviews focused on the application of BMNs in cancer diagnoses (sensing, and imaging) and rarely mentioned the application of the treatment of cancer. The purpose of this review is to provide a comprehensive perspective on the recent progress of BNMs as therapeutic agents. We first introduce and discuss the synthesis methods, intrinsic properties (size, morphology, and structure), and optical and catalytic properties relevant to cancer therapy. Then, we highlight the application of BMNs in cancer therapy (e.g., drug/gene delivery, radiotherapy, photothermal therapy, photodynamic therapy, enzyme-mediated tumor therapy, and multifunctional synergistic therapy). Finally, we put forward insights for the forthcoming in order to make more comprehensive use of BMNs and improve the medical system of cancer treatment.
format Online
Article
Text
id pubmed-9783205
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97832052022-12-24 Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy Niu, Guiming Gao, Fucheng Wang, Yandong Zhang, Jie Zhao, Li Jiang, Yanyan Molecules Review Bimetallic nanomaterials (BMNs) composed of two different metal elements have certain mixing patterns and geometric structures, and they often have superior properties than monometallic nanomaterials. Bimetallic-based nanomaterials have been widely investigated and extensively used in many biomedical fields especially cancer therapy because of their unique morphology and structure, special physicochemical properties, excellent biocompatibility, and synergistic effect. However, most reviews focused on the application of BMNs in cancer diagnoses (sensing, and imaging) and rarely mentioned the application of the treatment of cancer. The purpose of this review is to provide a comprehensive perspective on the recent progress of BNMs as therapeutic agents. We first introduce and discuss the synthesis methods, intrinsic properties (size, morphology, and structure), and optical and catalytic properties relevant to cancer therapy. Then, we highlight the application of BMNs in cancer therapy (e.g., drug/gene delivery, radiotherapy, photothermal therapy, photodynamic therapy, enzyme-mediated tumor therapy, and multifunctional synergistic therapy). Finally, we put forward insights for the forthcoming in order to make more comprehensive use of BMNs and improve the medical system of cancer treatment. MDPI 2022-12-09 /pmc/articles/PMC9783205/ /pubmed/36557846 http://dx.doi.org/10.3390/molecules27248712 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Niu, Guiming
Gao, Fucheng
Wang, Yandong
Zhang, Jie
Zhao, Li
Jiang, Yanyan
Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy
title Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy
title_full Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy
title_fullStr Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy
title_full_unstemmed Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy
title_short Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy
title_sort bimetallic nanomaterials: a promising nanoplatform for multimodal cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783205/
https://www.ncbi.nlm.nih.gov/pubmed/36557846
http://dx.doi.org/10.3390/molecules27248712
work_keys_str_mv AT niuguiming bimetallicnanomaterialsapromisingnanoplatformformultimodalcancertherapy
AT gaofucheng bimetallicnanomaterialsapromisingnanoplatformformultimodalcancertherapy
AT wangyandong bimetallicnanomaterialsapromisingnanoplatformformultimodalcancertherapy
AT zhangjie bimetallicnanomaterialsapromisingnanoplatformformultimodalcancertherapy
AT zhaoli bimetallicnanomaterialsapromisingnanoplatformformultimodalcancertherapy
AT jiangyanyan bimetallicnanomaterialsapromisingnanoplatformformultimodalcancertherapy